Search
Eli Lilly and Co
LLYAdd to Watchlist
1164.410USD
+11.480+1.00%
Close 09-18 16:00（ET）
1.10TMarket Cap
41.30P/E TTM
After-hours 16:11 (ET)1164.010USD-0.990-0.09%
After-hours 16:11 (ET)Eli Lilly and Co (LLY) Stock Price Target & Forecast
Analyst Rating
Based on 34 analysts giving stock ratings to Eli Lilly and Co in the past month.
Buy
10 Strong Buy
17 Buy
6 Hold
1 Sell
0 Strong Sell
Target Price
1306.807USD+13.39%
LLY Analyst Recommendation Trends
In the current month, LLY has received 17 Buy Ratings, 6 Hold Ratings, and 1 Sell Ratings. LLY average Analyst price target in the last month is 1306.807.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
10
10
10
11
11
10
10
9
17
17
17
16
16
14
15
15
6
6
7
7
8
9
8
9
0
0
0
0
0
0
0
0
1
1
1
1
0
0
0
0
34
34
35
35
35
33
33
33
LLY Analyst Rating for Peer Comparison
Updated: Sep 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Bristol-Myers Squibb Co
BMY
5
6
18
2
0
31
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Financial Forecasting
Based on analysts' estimates, LLY EPS is projected to reach 9.906 in FY2026Q3, following reported EPS of 7.950 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
6.67
6.66
6.01
9.91
9.98
Actual
7.41
8.27
7.95
--
--
Surprise
+11.08%
+24.09%
+32.37%
--
--
FAQs
What is Eli Lilly and Co's expected revenue for the next quarter?
Eli Lilly and Co's expected revenue is 22.33B.
What is Eli Lilly and Co's price target?
Analysts forecast that Eli Lilly and Co's price target is USD 1.31K, with the highest forecast at USD 1.60K and the lowest forecast at USD 891.22.
How have Eli Lilly and CoLLY's recent earnings per share performed?
The market expectation was USD 7.95, while Eli Lilly and CoLLY's earnings per share (EPS) for the previous quarter was USD 8.27. EPS for the next quarter is expected at USD 9.91.
What is the analyst rating for Eli Lilly and Co?
Based on the ratings of Eli Lilly and Co's stock from 34 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.